Vivosim Lab Inc (VIVS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 03/31
| 03-2020 | 03-2019 | 03-2018 | 03-2017 | 03-2016 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -18,710 | -26,635 | -34,803 | -38,447 | -38,575 |
| Depreciation Amortization | 1,142 | 980 | 1,267 | 1,149 | 723 |
| Accounts receivable | 392 | 380 | -236 | -388 | -259 |
| Accounts payable and accrued liabilities | 92 | 164 | -707 | 384 | -600 |
| Other Working Capital | -998 | 24 | -2,245 | 669 | -89 |
| Other Operating Activity | 3,200 | 4,712 | 7,867 | 7,448 | 9,432 |
| Operating Cash Flow | $-14,882 | $-20,375 | $-28,857 | $-29,185 | $-29,368 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 747 | -76 | -222 | -1,343 | -2,100 |
| Purchase Sale Intangibles | N/A | N/A | -70 | 0 | -35 |
| Other Investing Activity | 0 | 0 | -70 | -48 | -35 |
| Investing Cash Flow | $747 | $-76 | $-292 | $-1,391 | $-2,135 |
| Cash Flows From Financing Activities | |||||
| Debt Repayment | N/A | N/A | N/A | 0 | -5 |
| Common Stock Issued | 4,996 | 13,377 | 10,207 | 31,247 | 43,457 |
| Other Financing Activity | -61 | -223 | -94 | 0 | 0 |
| Financing Cash Flow | $4,935 | $13,154 | $10,113 | $31,247 | $43,452 |
| Exchange Rate Effect | N/A | N/A | 11 | -11 | 0 |
| Beginning Cash Position | 36,556 | 43,853 | 62,878 | 62,091 | 50,142 |
| End Cash Position | 27,356 | 36,556 | 43,853 | 62,751 | 62,091 |
| Net Cash Flow | $-9,200 | $-7,297 | $-19,025 | $660 | $11,949 |
| Free Cash Flow | |||||
| Operating Cash Flow | -14,882 | -20,375 | -28,857 | -29,185 | -29,368 |
| Capital Expenditure | N/A | -79 | -226 | -1,354 | -2,114 |
| Free Cash Flow | -14,882 | -20,454 | -29,083 | -30,539 | -31,482 |